Cargando…
组织驻留记忆T细胞在肺癌中的研究进展
Immune checkpoint inhibitors (ICIs) have been widely used in the treatment of lung cancer, but the benefit population is limited and there is a lack of effective predictive markers of efficacy. Tissue-resident memory T cells (TRM) reside in tissues and exert anti-tumor effects by expressing the inte...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845087/ https://www.ncbi.nlm.nih.gov/pubmed/36617472 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.49 |